Genzyme Warned Over Procedures At Drug Plant
The FDA's warning letter detailing those deviations, sent to Genzyme on Feb. 27, was posted to the agency's Web site on Tuesday. They were discovered during a routine inspection of the company's manufacturing facility in Allston, Mass., in September and October 2008.
The letter cited...
To view the full article, register now.